Trial
NCT05381974
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
COMPASS Pathways
Condition
Treatment-Resistant Major Depressive Disorder
Intervention
Psilocybin
Why stopped
Study was terminated due to difficulty recruiting patients who met inclusion/exclusion criteria. No participants received the intervention.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-24